Naomi M. Sell

Naomi M. Sell

Auto-generated profile, based on publicly available information

Naomi M. Sell

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JKJesi Kim
Jesi Kim
TTTodd Thomsen
Todd Thomsen
NSNaomi Sell
Naomi Sell
AGAndrew J. Goldsmith
Andrew J. Goldsmith

1 September 2014 in Annals of Surgery
Verified
Journal Article
Closed access
LHLavu Harish
Lavu Harish
NSNaomi M. Sell
Naomi M. Sell
TCTimothy I. Carter
Timothy I. Carter
JWJordan M. Winter
Jordan M. Winter
DMDavid P. Maguire
David P. Maguire
CYCharles Yeo
Charles Yeo
This study was designed to determine whether the volume and type of fluid administered for pancreaticoduodenectomy impacts postoperative outcomes. Three percent hypertonic saline (HYS) has been suggested as a means of reducing the volume of fluid required to sustain tissue perfusion in the perioperative period. Between May 2011 and November 2013, patients undergoing pancreaticoduodenectomy were enrolled in an institutional review board-approved, single-center, prospective, parallel, randomized controlled trial (NCT 01428050), comparing lactated Ringers (LAR) (15 mL/kg/hr LAR intraoperation, 2 mL/kg/hr LAR postoperation) with HYS (9 mL/kg/hr LAR and 1 mL/kg/hr HYS intraoperation, 1 mL/kg/hr HYS postoperation). A total of 264 patients were randomized. Demographic variables between groups were similar. The HYS patients had a significantly reduced net fluid balance (65 vs 91 mL/kg, P = 0.02). The overall complication rate was reduced in the HYS group (43% vs 54%), with a relative risk of 0.79 [95% confidence interval (CI), 0.62-1.02; P = 0.073], factoring stratification for pancreas texture. After adjustment for age and weight, the relative risk was 0.75 [95% CI (0.58-0.96); P = 0.023]. The total number of complications was significantly reduced in the HYS group (93 vs 123), with an incidence rate ratio of 0.74 [95% CI (0.56-0.97); P = 0.027]. After adjustment for age and weight, the incidence rate ratio was 0.69 [95% CI (0.52-0.90); P = 0.0068]. Reoperations, length of stay, readmissions, and 90-day mortality were similar between groups. A moderately restrictive fluid regimen with HYS resulted in a statistically significant 25% reduction in complications when adjusted for age, weight, and pancreatic texture.

31 January 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NSNaomi M. Sell
Naomi M. Sell
ZFZhi Ven Fong
Zhi Ven Fong
CCCarlos Fernandez del Castillo
Carlos Fernandez del Castillo
Motaz QadanMotaz Qadan
Motaz Qadan
AWAndrew L. Warshaw
Andrew L. Warshaw
CFCristina R. Ferrone
Cristina R. Ferrone

1 June 2015 in Surgery
Verified
Journal Article
Closed access
NSNaomi M. Sell
Naomi M. Sell
MPMichael J. Pucci
Michael J. Pucci
SGSalil Gabale
Salil Gabale
BLBenjamin E. Leiby
Benjamin E. Leiby
ERErnest L. Rosato
Ernest L. Rosato
LHLavu Harish
Lavu Harish

6 October 2020 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NSNaomi M. Sell
Naomi M. Sell
YQYasmeen Z. Qwaider
Yasmeen Z. Qwaider
RGRobert N. Goldstone
Robert N. Goldstone
CCChristy E. Cauley
Christy E. Cauley
JCJames C. Cusack
James C. Cusack
HKHiroko Kunitake
Hiroko Kunitake

1 July 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
ZFZhi Ven Fong
Zhi Ven Fong
DCDavid C. Chang
David C. Chang
CHChin Hur
Chin Hur
GJGinger Jin
Ginger Jin
ATAngela Tramontano
Angela Tramontano
Motaz QadanMotaz Qadan
Motaz Qadan